| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018727 |
| Receipt No. | R000021635 |
| Official scientific title of the study | Prospective multi-center registry about clinical performance for the abdominal surgery using the absorbable adhesion barrier (INTERCEED) made of oxidized regenerated cellulose. |
| Date of disclosure of the study information | 2015/08/23 |
| Last modified on | 2017/06/21 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Prospective multi-center registry about clinical performance for the abdominal surgery using the absorbable adhesion barrier (INTERCEED) made of oxidized regenerated cellulose. | |
| Title of the study (Brief title) | Prospective multi-center registry about clinical performance for the abdominal surgery using the absorbable adhesion barrier (INTERCEED) made of oxidized regenerated cellulose. | |
| Region |
|
|
| Condition | ||
| Condition | Abdominal laparoscopic surgery for colon and rectum | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the clinical performance of oxidized regenerated cellulose INTERCEED adhesive barrier in abdominal surgery. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Adhesive Intestinal Obstruction |
| Key secondary outcomes | - Revision surgery
-- Revision surgery related to postoperative bleeding -- Revision surgery related to anastomotic leak/ drainage - Surgical Site Infection (SSI) -- Superficial incisional surgical site infection -- Deep incisional surgical site infection -- Organ surgical site infection - Anastomotic leak - Other adverse events that lead to therapeutic interventions (surgery and/ or medication that differ from the standard pathway of care) - Death |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Subjects who are 20 years or older
2. Subjects undergoing abdominal laparoscopic surgery 3. Subjects with the will of participating in the study, and provided written informed consent 4. Subjects in whom the use of INTERCEED may be considered during the planned surgery. |
|||
| Key exclusion criteria | 1. Subjects in whom the laparoscopic procedure needs to be converted to open surgery.
2. Patients in whom significant adhesive disease is already present at the inception of the procedure requiring adhesiolysis that impacts surgical time. 3. Subjects in whom a complete excision of the tumor could not be achieved. 4. Subjects with intraoperative intraperitoneal administration of chemotherapy. 5. Subjects with severe hepatic dysfunction, renal failure, heart disease and infectious disease. 6. Subjects in whom alternate adhesive prevention methods are used 7. Subjects in whom complete hemostasis could not be achieved at the location where INTERCEED was going to be used 8. Subjects in whom the location where INTERCEED was going to be used is considered infected 9. Subjects with history of severe drug allergy. 10. Subjects with allergy of oxidized regenerated cellulose. 11. Subjects in whom the treating physician does not feel that the application of INTERCEED is appropriate |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiko Watanabe |
| Organization | Kitasato University School of Medicine |
| Division name | Department of Surgery |
| Address | 1-15-1,kitasato,minami-ku,sagamihara-city,Kanagawa, Japan |
| TEL | 042-778-8111 |
| gekaw@med.kitasato-u.ac.jp | |
| Public contact | |
| Name of contact person | Masanori Naito |
| Organization | Kitasato University School of Medicine |
| Division name | Department of Surgery |
| Address | 1-15-1,kitasato,minami-ku,sagamihara-city,Kanagawa, Japan |
| TEL | 042-778-8111 |
| Homepage URL | |
| mnaito@kitasato-u.ac.jp | |
| Sponsor | |
| Institute | Johnson&Johnson K.K. Medical Company |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Johnson&Johnson K.K. Medical Company |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective, consecutive, multicenter, single-arm observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021635 |